ES2173169T3 - Analgesicos a base de 4-arilisoindol. - Google Patents

Analgesicos a base de 4-arilisoindol.

Info

Publication number
ES2173169T3
ES2173169T3 ES95904262T ES95904262T ES2173169T3 ES 2173169 T3 ES2173169 T3 ES 2173169T3 ES 95904262 T ES95904262 T ES 95904262T ES 95904262 T ES95904262 T ES 95904262T ES 2173169 T3 ES2173169 T3 ES 2173169T3
Authority
ES
Spain
Prior art keywords
arylisoindol
image
analgesic
analgesic based
arylisoindoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95904262T
Other languages
English (en)
Inventor
Richard J Carmosin
John R Carson
Philip Pitis
Robert B Raffa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Application granted granted Critical
Publication of ES2173169T3 publication Critical patent/ES2173169T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LOS 4-ARILISOINDOLES DE FORMULA (I) SON ANALGESICOS EFICACES QUE INCLUYEN LOS ESTEREOISOMEROS PURIFICADOS Y SALES ACEPTABLES FARMACEUTICAMENTE DE LOS MISMOS, EN DONDE (II) ES (III), (IV), (V) O (VI); R{SUP,B} ES HIDROXI O C{SUB,1-5} ALQUILCARBONILOXI.
ES95904262T 1993-12-23 1994-12-02 Analgesicos a base de 4-arilisoindol. Expired - Lifetime ES2173169T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/173,326 US5543530A (en) 1993-12-23 1993-12-23 4-arylisoindole analgesics

Publications (1)

Publication Number Publication Date
ES2173169T3 true ES2173169T3 (es) 2002-10-16

Family

ID=22631518

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95904262T Expired - Lifetime ES2173169T3 (es) 1993-12-23 1994-12-02 Analgesicos a base de 4-arilisoindol.

Country Status (14)

Country Link
US (1) US5543530A (es)
EP (1) EP0740657B1 (es)
JP (1) JP3541952B2 (es)
AT (1) ATE214049T1 (es)
AU (1) AU700505B2 (es)
CA (1) CA2179634C (es)
DE (1) DE69430074T2 (es)
DK (1) DK0740657T3 (es)
ES (1) ES2173169T3 (es)
IL (1) IL112110A0 (es)
MX (1) MX9500231A (es)
PT (1) PT740657E (es)
WO (1) WO1995017384A1 (es)
ZA (1) ZA9410280B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics
US5602167A (en) * 1995-05-17 1997-02-11 Ortho Pharmaceutical Corporation 4-arylcyclohepta[c] pyrrole analgesics
CA2495589A1 (en) * 2002-08-14 2004-02-26 Abbott Laboratories Azabicyclic compounds are central nervous system active agents
US7135484B2 (en) 2002-08-14 2006-11-14 Abbott Laboratories Azabicyclic compounds are central nervous system active agents
CN102911108A (zh) * 2012-11-16 2013-02-06 葛长乐 一种反式全氢异吲哚及其盐的制备方法
EP3978497A4 (en) * 2019-05-30 2022-07-13 Shanghai Institute of Materia Medica, Chinese Academy of Sciences FUSED CYCLIC COMPOUND, METHOD FOR PREPARING IT AND ITS USE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042707A (en) * 1976-02-19 1977-08-16 E. I. Du Pont De Nemours And Company 3α-Arylhydroisoindoles
US4689329A (en) * 1986-02-04 1987-08-25 Mcneilab, Inc. 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
FR2654726B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone et leur preparation.
US5216018A (en) * 1992-02-14 1993-06-01 Du Pont Merck Pharmaceutical Company Hydroisoindolines and hydroisoquinolines as psychotropic
US5508424A (en) * 1993-03-26 1996-04-16 Ortho Pharmaceutical Corporation 4-arylisoindole analgesics

Also Published As

Publication number Publication date
JPH09507064A (ja) 1997-07-15
PT740657E (pt) 2002-07-31
AU700505B2 (en) 1999-01-07
EP0740657A1 (en) 1996-11-06
AU1301895A (en) 1995-07-10
DE69430074T2 (de) 2002-09-05
EP0740657B1 (en) 2002-03-06
CA2179634C (en) 2005-09-13
US5543530A (en) 1996-08-06
IL112110A0 (en) 1995-03-15
DK0740657T3 (da) 2002-06-24
CA2179634A1 (en) 1995-06-29
ATE214049T1 (de) 2002-03-15
JP3541952B2 (ja) 2004-07-14
ZA9410280B (en) 1996-06-24
DE69430074D1 (de) 2002-04-11
MX9500231A (es) 1997-02-28
WO1995017384A1 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
MY132705A (en) Novel compounds with analgesic effect
MY115662A (en) Novel compounds with analgesic effect
ES8605821A1 (es) Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
LU91452I2 (fr) "Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)"
AU6613896A (en) Chemical compounds
LU91538I2 (fr) Mavacoxib/TrocoxilCommercialisé sous forme: Mavacoxib, ou facultativement sous forme d'un sel pharmaceutiquement acceptable
ATE181551T1 (de) Taxol-derivate
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
FR2757397B1 (fr) Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
HK22997A (en) Substituted 4-phenyl-4-piperidine-carboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
FI934680A (fi) Arylmorfolin, framstaellning och anvaending
ES2173169T3 (es) Analgesicos a base de 4-arilisoindol.
MXPA03001081A (es) Medicamento anti-inflamatorio.
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
SE9504267D0 (sv) New therapeutic use
ES8800916A1 (es) Un procedimiento para preparar acidos beta-lactamo-hidroxamicos sulfatados en o
SE9603284D0 (sv) New compounds
IL127930A0 (en) Verapamil as a medicament for the treatment of angina
DE69905144D1 (de) N,N'-Diacylthiocystine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 740657

Country of ref document: ES